PREVALENCE RATES OF HEALTH IMPAIRMENTS DUE TO MALIGNANT NEOPLASMS IN THE RUSSIAN FEDERATION

2020 ◽  
Vol 2 ◽  
pp. 40-48
Author(s):  
G.E. Pogosyan ◽  
◽  
N.V. Maslikhova ◽  
S.N. Puzin ◽  
M.A. Shurgaya ◽  
...  
Keyword(s):  
Russian Federation ◽  
Malignant Neoplasms ◽  
Prevalence Rates ◽  
The Russian Federation ◽  
Health Impairments

Malignant mesothelioma in the Russian Federation

2020 ◽  
pp. 646-646
Author(s):  
E. V. Kovalevskiy ◽  
S. V. Kashanskiy ◽  
I. M. Tskhomariia
Keyword(s):  
Malignant Mesothelioma ◽  
Russian Federation ◽  
Preventive Measures ◽  
Convincing Evidence ◽  
Malignant Neoplasms ◽  
Asbestos Fibers ◽  
The Russian Federation

One of the malignant neoplasms, which is associated with exposure to only one factor - asbestos fibers, is malignant mesothelioma. At the same time, today there is already convincing evidence of its polyetiology. This indicates the urgent need to expand research in this direction in order to develop targeted preventive measures.

scholarly journals THE DISABILITY OF CITIZEN OF ELDERLY AGE IN THE RUSSIAN FEDERATION

2019 ◽  
Vol 61 (6) ◽  
pp. 292-299
Author(s):  
Marina A. Shurgaya
Keyword(s):  
Social Support ◽  
Health Care ◽  
Russian Federation ◽  
Disabled Persons ◽  
Regional Differentiation ◽  
Malignant Neoplasms ◽  
Urogenital System ◽  
Elderly Age ◽  
Gender Characteristics ◽  
The Russian Federation

During the period of health care reforming, study of a true picture of population health and medical social needs in particular age-gender groups, including elderly age, is a necessary condition for planning development of health care, social support and scientific substantiation of prevention programs. The article presents the results of comparative analysis of indices of disability of main age groups of adult population of the Russian Federation during 2005-2016. The methods of study: documentary, data sampling, statistical and graphic techniques. The volume of study made up to 34,840,933 individuals aged from 18 years and older, recognized as disabled, including disabled persons of elderly age - 12,971,062 individuals. The established characteristics of primary and repeated disability of citizen of elderly age in the Russian Federation (gender characteristics, nosological structure, regional differentiation) are covered that reflect demographic tendencies of aging of population. The dynamics of disability of citizen of elderly age during long term period (2005-2016) testifies alteration of ratio between primary and repeated established cases of disability. In 2005 overwhelming exceeding of primary recognized as disabled persons over repeatedly recognized was marked: 81.2% against 18.9%. In 2016 in total contingent of the examined the disabled persons with repeatedly established disability prevailed: 62.7% against 37.3%. During the period of observation, the level of repeatedly established disability among citizen of elderly age increased up to 74,5% (R2 = 0,546), whereas in contingents of young and middle age is marked a stable tendency to decreasing of value of indicator (R2 = 0,934, R2 = 0,5873 correspondingly). The citizen of elderly age prevails in the structure of disability due to malignant neoplasms, diseases of blood circulation system, diseases of musculoskeletal system and connective tissue, diseases of eye, ear and mastoid bone, diseases of endocrine, nervous and urogenital system. In connection with high invalidation, the elderly category of population is in need of significant medical social support. The development of activities targeted to medical social rehabilitation of citizen of elderly age it is appropriate considering regional differentiation of the subjects in the Russian Federation related to prevalence of disability and also gender characteristics of disability.

scholarly journals Economic consequences of mandatory price re-registration for medicines from the high-cost nosology program

2020 ◽  
pp. 27-33
Author(s):  
A. V. Rudakova ◽  
D. T. Ugrekhelidze ◽  
V. A. Krylov
Keyword(s):  
Russian Federation ◽  
Economic Consequences ◽  
Malignant Neoplasms ◽  
Selling Price ◽  
Pricing Policy ◽  
Essential Drug List ◽  
Before And After ◽  
The Russian Federation ◽  
The Government ◽  
Reference Stock

The Government Decree, approved in December 2019, required registration certificates holders of reference drugs, included in the essential drug list (EDL), submit applications for mandatory price re-registration. Drugs included in the high-cost nosology list (high-cost list) must be included in the EDL.Objective: to assess the budget impact of price re-registration for high-cost list drugs.Material and methods. The comparing economic analysis of high-cost nosology program before and after price re-registration based on the Government Decree N 1683 (effective from 16.12.2019). 125 reference stock keeping units (SKUs), included in the high-cost list, were evaluated.Results. The analysis showed, that after re-registration the prices of 66 SKUs will remain the same. The prices of 43 reference SKUs will be reduced after setting a single maximum selling price («equalization»). Prices for 16 SKUs will be reduced due to lower registered prices in the reference countries. Considering the contracts executed in 20192020, the budget of the high-cost program is up to 74.430 billion rubles, and after re-registration it will be equal to 64.162 billion rubles, so the savings will amount 10.267 billion (13.8 %). The main drivers of re-registration prices savings are: Advagraf (1.175 billion rubles), Elizaria (2.083 billion rubles) and Revlimid (2.247 billion rubles). Separately, we analyzed the consequences ofprices re-registration in the V-thgroup ofhigh-cost list, which are provided topatients with malignant neoplasms of lymphoid, hematopoietic and related tissues. It was calculated, that in 2019 the contracts for V-th group of high-cost list were signed for 19.217 billion rubles, and after the price re-registration for the purchase of the same number of drugs 16.762 billion rubles will be spent, so the savings from the price re-registration will amount to 2.455 billion rubles (12.8 %), among which 2.247 billion rubles will be provided by price re-registration of Revlimid.Conclusions. The pricing policy implemented in the Russian Federation is aimed at increasing the availability of highly effective medical care to the population of the Russian Federation and significantly reduces the burden on the budget of the healthcare system.

scholarly journals Analysis of the correspondence of the lists of drugs for cancer patients' treatment included in the territorial programs of state guarantees to the list of vital and essential drugs

2021 ◽  
Vol 65 (2) ◽  
pp. 111-117
Author(s):  
Alexander B. Zudin ◽  
Sergey A. Linnik ◽  
Oxana Yu. Alexandrova
Keyword(s):  
Russian Federation ◽  
Complete List ◽  
Malignant Neoplasms ◽  
Outpatient Basis ◽  
State Program ◽  
Treatment Regimens ◽  
Territorial State ◽  
Essential Drugs ◽  
Federal Districts ◽  
The Russian Federation

The aim of the study was to study the compliance of the list of drugs for the treatment of malignant neoplasms in the territorial state guarantee programs (TSGP) with the list of vital and essential drugs (VED) in the constituent entities of the Russian Federation and the practice of purchasing drugs at the expense of regional preferential provision (RPP) funds. Material and methods. The analyzed territorial programs of state guarantees were compared with the list of drugs for RPP for the patients with malignant neoplasms with the VED. An assessment of medication procurement in 2019 and 2020 was carried out and compared with the current list of RLO in all constituent entities of the Russian Federation. Results. Only 14% of the Russian Federation regions in 2019 and 20% in 2020 met the territorial state program of guarantees requirement. The average number of medications included in the territorial state program of guarantees was 73 INNs in 2019 and 100 INNs in 2020. The number of regions with a complete list of drugs accounted for 7% to 33% in the corresponding Federal Districts. In 2020 the number of regions with a complete list of medications in a territorial program of state guarantees did not change. Discussion. Reduction of medications from the VED purchased at the expense of RPP reduces the number of possible treatment regimens, and limits oncologists’ ability to provide care on an outpatient basis. Conclusion. Most Russian Federation regions violate the requirements of the territorial program of state guarantees do not harmonize the list of medications in the Program with EDL. The practice of purchasing medications from the territorial program of state guarantees indicates the absence of finance mechanisms for providing medications to patients at the outpatient stage of treatment.

scholarly journals Clinical and Epidemiological Analysis of Morbidity and Mortality from Malignant Neoplasms among Employees of Radiation Hazardous Enterprises and the Population Living Near Nuclear Industry and Nuclear Power Facilities

2021 ◽  
pp. 42-46
Author(s):  
A.P. Biryukov ◽  
◽  
E.P. Korovkina ◽  
E.V. Vasilyev ◽  
Yu.V. Orlov ◽  
...  
Keyword(s):  
Medical Treatment ◽  
Russian Federation ◽  
Nuclear Power ◽  
Power Plants ◽  
Nuclear Industry ◽  
Morbidity And Mortality ◽  
Malignant Neoplasms ◽  
Time Interval ◽  
Depth Analysis ◽  
The Russian Federation

The purpose of the study is to analyze the oncoepidemiological situation in the vicinity of nuclear industry and nuclear power plants. Materials and methods of the study. The main materials of the study were the data of official medical statistics for 2012-2018 on the incidence of malignant neoplasms and mortality from them: the contingent of medical treatment organizations of FMBA of Russia in 10 closed administrative-territorial formations of Rosatom State Corporation — a research sample; total contingent served by medical treatment organizations of FMBA of Russia — data of the Federal Center for Extreme Problems Information Technology of FMBA of Russia; population of Russian Federation as a whole. An in-depth analysis of the morbidity and mortality from malignant neoplasms among employees of enterprises and the population served by medical treatment organizations of FMBA of Russia was performed using data from the Branch Cancer Registry of FMBA of Russia. Results of the study and their analysis. According to the results of the analysis an increase in the incidence of malignant neoplasms was observed in medical treatment organizations of the Federal Medical and Biological Agency of Russia in closed administrative territorial formations, in all medical treatment organizations of the Federal Medical and Biological Agency of Russia, and in the Russian Federation as a whole. In 2012-2018 the incidence of malignant neoplasms (per 100,000 population) was: in closed administrative territorial entities — 412.4 and 526.6 respectively; in all medical treatment institutions of FMBA of Russia — 328.4 and 390.1; in the Russian Federation as a whole — 367.3 and 425.5 respectively. Analysis of mortality rates from malignant neoplasms showed that in all medical treatment institutions of the Federal Medical and Biomedical Agency of Russia the mortality rate from malignant neoplasms (per 100 thousand population) in this time interval was 149.1 and 167.9 persons respectively, which is significantly lower than the all-Russian rates of 201.0 and 200.0 persons respectively. Mortality from malignant neoplasms in closed administrative territorial units amounted to 220.1 and 257.3 persons respectively, which exceeds both all medical treatment institutions of the Federal Medical and Biological Agency and the Russian Federation as a whole.

scholarly journals Clinical and epidemiological rationale for prevention of uterus cancer

2020 ◽  
pp. 59-62
Author(s):  
T. V. Klinyshkova
Keyword(s):  
Cervical Cancer ◽  
Cancer Prevention ◽  
Russian Federation ◽  
Cancer Incidence ◽  
Reproductive System ◽  
Malignant Neoplasms ◽  
Epidemiological Features ◽  
The Russian Federation ◽  
The Stability ◽  
Uterine Body

Introduction. Malignant neoplasms of the reproductive system dominate the structure of cancer incidence in women in the Russian Federation. In the structure of oncogynecological diseases, uterine body cancer (UBC) leads the way.The purpose of the study: to analyze the dynamics of UBC incidence in the Omsk region in comparison with data for the Russian Federation in 2002–2018 years to determine the priorities of cancer prevention.Results. There was a moderate tendency to increase the incidence of UBC in the region (Rg. = +1.8 %; p < 0.001) and for the Russian Federation (Rg. = +1.7 %; p < 0.001). The maximum percentage was among patients of 60–69 years old (32.3 %). There was a moderate trend in increasing UBC among women of 30–39 years old, and in the group of women of 35–39 years old there was a distinct trend in increasing the incidence (Rg. = +5.6 %; p < 0.050). The article presents the epidemiological features of UBC in comparison with cervical cancer in the region: the increase in the incidence of UBC (Rg. =+1.8 %) and the stability of the indicator at cervical cancer (Rg. = +0.050 %), the trend to rejuvenate both locations of cancer.Conclusion. In Omsk Region, there is a unidirectional increase in the incidence of UBC with the Russian Federation, a trend in rejuvenating the disease, which dictates the need for cancer prevention in the practice of an obstetrician-gynecologist.

scholarly journals Morbidity of the working-age population of the Russian Federation for 2015–2019

2021 ◽  
Vol 100 (12) ◽  
pp. 1487-1494
Author(s):  
Aleksandr S. Shastin ◽  
Olga L. Malykh ◽  
Venera G. Gazimova ◽  
Tatyana M. Tsepilova ◽  
Tatyana S. Ustyugova
Keyword(s):  
Health Status ◽  
Russian Federation ◽  
Disease Incidence ◽  
Adult Population ◽  
National Level ◽  
Economic Losses ◽  
Prevalence Rates ◽  
Working Age ◽  
The Russian Federation ◽  
Working Age Population

Introduction. The quality of labour potential is one of the most important factors of economic growth, which largely depends on the health status of the working-age population. Today, incidence and prevalence rates in the Russian working-age population are not monitored at the national level. Materials and methods. We conducted a descriptive epidemiological study based on retrospective data on disease incidence in the adult population of the Russian Federation. We also assessed disease incidence and prevalence in the Russian working-age population (men aged 18-59 and women aged 18-54) in 2015-2019 using the method of continuous observation. We estimated and ranked incidence and prevalence rates per 100,000 working-age population of some constituent entities and federal districts of the Russian Federation to establish the territories with the highest and lowest rates. Results. We applied and tested methodological approaches to assessing the morbidity of the working-age population living in different regions of the Russian Federation. Our findings demonstrate a high degree of variability in both incidence and prevalence rates in the working-age population in general and by ICD-10 disease categories. Conclusion. Results of our assessments and ranking of the constituent entities of the Russian Federation by disease-specific incidence and prevalence rates in the working-age population provide an opportunity to areas at risk with specific health status enabling the most efficient management of risks of labour and economic losses. The proven method approaches may be used to address the challenges of public health monitoring.

scholarly journals REPEATED DISABILITY DUE TO CANCER IN THE CHECHEN REPUBLIC

2018 ◽  
Vol 21 (3-4) ◽  
pp. 152-155
Author(s):  
Liliya S. Idrisova
Keyword(s):  
Young People ◽  
Russian Federation ◽  
Adult Population ◽  
The Elderly ◽  
Malignant Neoplasms ◽  
Middle Aged ◽  
Growth Trend ◽  
The Russian Federation ◽  
Visibility Index ◽  
Negative Growth

The article presents the results of a study of the dynamics of recurrent disability due to malignant neoplasms (ZNO) of the adult population in the Chechen Republic for the period 2008-2017. in comparison with the figures for the Russian Federation. In the Russian Federation, the dynamics of re-disability of the adult population due to the ZNO in the period 2008-2017 was characterized by an increase in the number of repeatedly recognized disabled (PPI), the level of which increased from 19.9 to 27.0 per 10 thousand people. Compared to 2008 (taken as 100%), the indicator of visibility of PPI was 135%. In the PPI contingent, the elderly prevailed with a negative trend of growth in their numbers. The proportion of young and middle-aged PPI decreased. In the Chechen Republic, the epidemiological picture of the disability of the adult population due to the ZNO was characterized by different dynamics. The number of PPI due to ZNO in the country decreased. Compared to 2008 (taken as 100%), the visibility index of the PPI was 57.0%; In the structure of recurrent disability due to ZNO, middle-aged and old-aged PPI prevailed, however, their proportion declined. There is a negative growth trend in the proportion of young people.

scholarly journals Prevalence and Incidence of Multiple Sclerosis in Russian Federation: 30 Years of Studies

2020 ◽  
Vol 10 (5) ◽  
pp. 305 ◽  
Author(s):  
Alexey Boyko ◽  
Mikhail Melnikov
Keyword(s):  
Multiple Sclerosis ◽  
Russian Federation ◽  
Risk Profile ◽  
Incidence Rates ◽  
Steady Increase ◽  
Prevalence Rates ◽  
Ratio Increase ◽  
Male Ratio ◽  
The Russian Federation ◽  
Multiple Sclerosis Epidemiology

In the Russian Federation, multiple sclerosis prevalence rates vary from 10 to 80 cases per 100,000, depending on region and the nationality of the population. The main characteristics of multiple sclerosis epidemiology in the XX century in this big territory are: (1) steady increase in multiple sclerosis prevalence and incidence rates, maybe because of better diagnosis and treatment, but also changes in environmental/epigenetic risk profile and/or lifestyle factors; (2) increase of the female to male ratio, increase in multiple sclerosis incidence mainly in females; (3) appearance and increasing frequency of multiple sclerosis in ethnic groups, previously free of multiple sclerosis (Northern Tribes, Yakuts and others). The latest data show that in European Russia, the multiple sclerosis prevalence varies from 30 to 80 cases, in Siberia—from 20 to 70 cases, with steady increases, especially in women.

Sign in / Sign up

Export Citation Format

Share Document